Axim Biotechnologies Inc Asset Turnover Ratio (AXIM), as of second quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Axim Biotechnologies Inc   (AXIM)
 

Axim Biotechnologies Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Axim Biotechnologies Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.02 in the second quarter (Jun 30 2024)

Within sector 212 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2024 compared to the preceding quarter from 2720 to 3853.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AXIM Asset Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Asset Change -12.21 % -2.68 % -2.15 % -7.17 % -0.92 %
Y / Y Revenue Change 76.04 % 616.22 % 66.79 % 629.15 % -
Asset Turnover Ratio (TTM) 0.02 0.02 0.01 0.01 0.01
AXIM's Total Ranking # 3853 # 2720 # 3616 # 3961 # 4037
Seq. Asset Change -5.26 % -4.53 % 1.92 % -4.77 % 5.03 %
Seq. Revenue Change -67.01 % 320.1 % 31.63 % -3.5 % 34.23 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 213
Healthcare Sector # 568
Overall Market # 3853

Asset Turnover Ratio Statistics
High Average Low
0.32 0.07 -0.03
(Dec 31 2019)   (Sep 30 2021)




AXIM Company Profile • Back to AXIM Efficiency Comparisons • Compare AXIM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Aligos Therapeutics Inc   0.07 $ 7.967  Millions$ 118.523  Millions
Lexaria Bioscience Corp   0.07 $ 0.377  Millions$ 5.635  Millions
Keros Therapeutics Inc   0.06 $ 26.210  Millions$ 409.278  Millions
Stoke Therapeutics Inc   0.06 $ 15.156  Millions$ 245.293  Millions
Merus N v   0.06 $ 35.193  Millions$ 584.498  Millions
Omniab Inc   0.06 $ 21.714  Millions$ 364.188  Millions
Lineage Cell Therapeutics Inc   0.06 $ 6.186  Millions$ 104.614  Millions
Northwest Biotherapeutics Inc  0.06 $ 1.645  Millions$ 29.037  Millions
Bicycle Therapeutics Plc  0.06 $ 39.574  Millions$ 709.631  Millions
Oncternal Therapeutics Inc   0.06 $ 1.846  Millions$ 33.231  Millions
Werewolf Therapeutics Inc   0.05 $ 9.283  Millions$ 170.630  Millions
Mountain Crest Acquisition Corp V  0.05 $ 0.294  Millions$ 5.743  Millions
Soligenix inc   0.05 $ 0.495  Millions$ 9.756  Millions
Immunome Inc   0.05 $ 10.784  Millions$ 214.418  Millions
Volitionrx Limited  0.05 $ 0.977  Millions$ 19.624  Millions
Nexalin Technology Inc   0.05 $ 0.150  Millions$ 3.116  Millions
Inovio Pharmaceuticals Inc   0.05 $ 7.157  Millions$ 156.740  Millions
Sab Biotherapeutics Inc   0.05 $ 2.780  Millions$ 61.385  Millions
Foxo Technologies Inc   0.05 $ 0.155  Millions$ 3.439  Millions
Femasys Inc   0.04 $ 0.950  Millions$ 21.814  Millions
Lumos Pharma Inc   0.04 $ 1.486  Millions$ 34.456  Millions
Vir Biotechnology Inc   0.04 $ 78.877  Millions$ 1,856.870  Millions
Kronos Bio Inc   0.04 $ 8.411  Millions$ 199.631  Millions
4d Molecular Therapeutics Inc   0.04 $ 20.219  Millions$ 487.876  Millions
Tscan Therapeutics Inc   0.04 $ 12.200  Millions$ 294.808  Millions
Viskase Holdings inc   0.04 $ 1.934  Millions$ 47.131  Millions
Generation Bio Co   0.04 $ 13.174  Millions$ 326.848  Millions
Astrotech Corp  0.04 $ 1.664  Millions$ 41.327  Millions
Abeona Therapeutics Inc   0.04 $ 3.370  Millions$ 84.730  Millions
Proqr Therapeutics N v   0.04 $ 6.788  Millions$ 171.271  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.